Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Blood|March 29, 2013
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialHong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, et al.
Journal of Medical Virology|February 19, 2024
Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathwaysDong Yang, Jasper Fuk-Woo Chan, Chaemin Yoon, et al.
Research Square|November 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Huiping Shuai, Jingxin Qiao, et al.
Nature|January 21, 2022
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 OmicronHuiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Cell Reports. Medicine|September 9, 2022
Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2Jasper Fuk-Woo Chan, Bingjie Hu, Yue Chai, et al.
JCI Insight|April 21, 2022
Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 miceBao-Zhong Zhang, Huiping Shuai, Hua-Rui Gong, et al.
Ebiomedicine|December 15, 2023
Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Jasper Fuk-Woo Chan, Yuanchen Liu, et al.
Ebiomedicine|August 14, 2023
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5Huiping Shuai, Jasper Fuk-Woo Chan, Bingjie Hu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2021
Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian HamstersJasper Fuk Woo Chan, Vincent Kwok Man Poon, Chris Chung Sing Chan, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 3, 2020
SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19Hin Chu, Jasper Fuk-Woo Chan, Yixin Wang, et al.
Pageof 14